These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24708032)

  • 1. Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology.
    Piper A; Song Y; Eves ND; Maher TM
    Respirology; 2014 Apr; 19(3):428-37. PubMed ID: 24708032
    [No Abstract]   [Full Text] [Related]  

  • 2. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology.
    Eves ND; Song Y; Piper A; Maher TM
    Respirology; 2013 Apr; 18(3):555-64. PubMed ID: 23336426
    [No Abstract]   [Full Text] [Related]  

  • 3. Year in review 2009: Interstitial lung diseases, acute injury, sleep, physiology, imaging and bronchoscopic intervention.
    Eastwood PR; Maher TM; Wells AU; Lam B
    Respirology; 2010 Jan; 15(1):172-81. PubMed ID: 20199638
    [No Abstract]   [Full Text] [Related]  

  • 4. Respirology year-in-review 2008: basic science.
    Kolb MR; Yang I
    Respirology; 2009 Apr; 14(3):318-26. PubMed ID: 19353767
    [No Abstract]   [Full Text] [Related]  

  • 5. Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer.
    Takahashi K; Eves ND; Piper A; Song Y; Maher TM
    Respirology; 2012 Apr; 17(3):554-62. PubMed ID: 22248252
    [No Abstract]   [Full Text] [Related]  

  • 6. Year in review 2010: interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer.
    Eastwood PR; Takahashi K; Lee P; Maher TM
    Respirology; 2011 Apr; 16(3):553-63. PubMed ID: 21244574
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS).
    Mukhopadhyay S; Parambil JG
    Semin Respir Crit Care Med; 2012 Oct; 33(5):476-85. PubMed ID: 23001802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
    Vandenbroucke RE; Dejonckheere E; Libert C
    Eur Respir J; 2011 Nov; 38(5):1200-14. PubMed ID: 21659416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining lung injury in animals.
    Zarogiannis SG; Matalon S
    Am J Respir Cell Mol Biol; 2013 Feb; 48(2):267. PubMed ID: 23378486
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply: defining lung injury in animals.
    Matute-Bello G; Downey GP
    Am J Respir Cell Mol Biol; 2013 Feb; 48(2):267-8. PubMed ID: 23487848
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Year in Review II: interstitial lung disease, sepsis, pulmonary infections, and sleep medicine.
    Moss M
    Proc Am Thorac Soc; 2007 Sep; 4(6):482-8. PubMed ID: 17761963
    [No Abstract]   [Full Text] [Related]  

  • 12. Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease.
    Troy LK; Young IH; Lau EMT; Wong KKH; Yee BJ; Torzillo PJ; Corte TJ
    Respirology; 2019 Oct; 24(10):996-1004. PubMed ID: 30933419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbations of interstitial lung diseases.
    Papanikolaou IC; Drakopanagiotakis F; Polychronopoulos VS
    Curr Opin Pulm Med; 2010 Sep; 16(5):480-6. PubMed ID: 20473169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical year in review I: interstitial lung disease, occupational and environmental lung disease, education of residents and fellows, and pediatrics.
    Schmidt SL; Flaherty KR
    Proc Am Thorac Soc; 2011 Sep; 8(5):389-97. PubMed ID: 21926388
    [No Abstract]   [Full Text] [Related]  

  • 15. Selected clinical highlights from the 2012 ERS congress in Vienna.
    Marvisi M; Herth FJ; Ley S; Poletti V; Chavannes NH; Spruit MA; Clini E; Cottin V
    Eur Respir J; 2013 May; 41(5):1219-27. PubMed ID: 23222869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
    Frank AL; Kreuter M; Schwarzkopf L
    Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of fibrotic interstitial lung disease.
    Churg A; Wright JL; Tazelaar HD
    Histopathology; 2011 Mar; 58(4):525-30. PubMed ID: 20854464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse alveolar damage.
    Poletti V; Casoni GL; Cancellieri A; Piciucchi S; Dubini A; Zompatori M
    Pathologica; 2010 Dec; 102(6):453-63. PubMed ID: 21428112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sleep and chronic lung diseases: diffuse interstitial lung diseases, bronchial asthma, and COPD].
    Cabral MM; Mueller Pde T
    J Bras Pneumol; 2010 Jun; 36 Suppl 2():53-6. PubMed ID: 20944983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.